参考文献/References:
［1］Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop ［J］.Arthritis Rheum 1999，42（7）:13091311.
［2］Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) ［J］. J Thromb Haemost, 2006,4(2):295306.
［3］Arachchillage DR, Machin SJ, Mackie IJ, et al. Diagnosis and management of noncriteria obstetric antiphospholipid syndrome［J］. Thromb Haemost, 2015, 113(1):1319.
［4］张文．抗磷脂综合征治疗进展 ［J］．中国实用内科杂志,2017,37(2)：120123．
［5］Saccone G，Berghella V，Maruotti G M，et al． Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PＲEGNANTS study ［J］．Am J Obstet Gynecol,2017,216(5) : 525．e 1525．e 12.
［6］Marchetti T, De Moerloose P, Gris J C.Antiphospholipid antibodies and the risk of severe and nonsevere preeclampsia: the NOHA casecontrol study ［J］. Journal of Thrombosis and Haemostasis : JTH, 2016, 14(4): 675684.
［7］Salle V, Schmidt J, Smail A, et al. Antibodies directed against annexin A2 and obstetric morbidity ［J］. Journal of Reproductive Immunology, 2016, 118: 5053.
［8］Becarevic M, Stojanovic L, Ignjatovic S, et al. The IgM isotype of antiannexin A5 antibodies and multiple positivity of conventional antiphospholipid antibodies: increasing the number of clinical manifestations of primary antiphospholipid syndrome ［J］. Clinical Rheumatology, 2016, 35(5): 13611365.
［9］Amengual O, Forastiero R, SugiuraOgasawara M, et al. Evaluation of phosphatidylserinedependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicenter study ［J］. Lupus, 2017, 26(3): 266276.
［10］Chighizola CB, Gerosa M, Trespidi L, et al. Update on the current commendations and outcomes in pregnant women with antiphospholipid syndrome ［J］ . Expert Rev ClinImmunol , 2014 , 10 (11): 15051517 .
［11］曹向一,于月新．低分子肝素在生殖领域的临床应用 ［J］ .实用妇产科杂志,2019 , 35 (8): 584587 .
［12］Silver RM, Parker CB, Reddy UM, et al. Antiphospholipid antibodies in stillbirth ［J］. Obstet Gynecol , 2013,122（3）:641657.
［13］Tektonidou MG, Laura Andreoli, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults ［J］. Ann Rheum,2019,78（10）:12961304.
［14］Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome:clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients ［J］. Arthritis Rheum, 2002,46(4):10191027.
［15］Prado AD, Piovesan DM, Staub HL, et al. Association of anticardiolipin antibodies with preeclampsia: a systematic review and metaanalysis ［J］. Obstet Gynecol ,2010,116（6）:14331443.
［16］ American College of Obstetricians and Gynecologists.ACOG practice bulletin no.202. Gestational hypertension and preeclampsia ［J］.Obstet Gynecol, 2019, 133：e 1e 25.
［17］ Yamada H, Atsumi T, Kobashi G, et al. Antiphospholipid antibodies increase the risk of pregnancyinduced hypertension and adverse pregnancy outcomes ［J］. Reprod Immunol, 2009, 79(2):188195.
［18］ Micaela Fredi,Laura Andreoli, Elena A , et al. Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: results from a multicenter study of 283 pregnancies［J］.Front Immunol,2018,9 : 864.
［19］ 宋文惠，杨孜,郭宏霞，等.抗磷脂综合征合并妊娠不同干预时机及干预方法抗早产效果研究 ［J］.中国实用妇科与产科杂志, 2016, 32 (10)：973978.
［20］杨孜. 加深认识和注重防范早产临产因素之自身免疫性疾病［J］.中国计划生育和妇产科,2018, 10(11): 37.
［21］Hoayek JG, Moussa HN, Rehman HA, et al. Catastrophic antiphospholipid syndrome in pregnancy, a diagnosis that should not be missed［J］. Matern Fetal Neonatal Med, 2016,29(24):39503955.
［22］曾桢,周炜,等.妊娠期灾难性抗磷脂综合征一例报告及文献复习 ［J］.中华围产医学杂志,2018, 21(9):604609.
［23］Cervera R, RodríguezPintó I, Colafrancesco S, et al. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome ［J］. Autoimmun Rev, 2014, 13(7):699707.
［24］ Hanouna G, Morel N, LeTHD , et al . Catastrophic antiphospholipid syndrome and pregnancy: an experience of 13 cases ［J］. Rheumatology (Oxford), 2013,52(9):16351641.
［25］赵爱民．低分子肝素防治自然流产中国专家共识 ［J］.中华生殖与避孕杂志,2018,38(9)：701708.
［26］Mekinian A, Lazzaroni MG, Kuzenko A, et al. The efficacy of hydroxychloroquine for obstetrical outcome in antiphospholipid syndrome: data from a European multicenter retrospective study［J］. Autoimmun Rev , 2015, 14(6):498502.
［27］Bramham K， Thomas M， NelsonPiercy C， et al． Firsttrimester lowdose prednisolone in refractory antiphospholipid antibodyrelated pregnancy loss ［J］．Blood,2011,117(25):69486951.
［28］郭宏霞，杨孜. 妊娠合并自身免疫性疾病临床监察与处理 ［J］.中国实用妇科与产科杂志, 2014, 30 (6)：403406.
［29］ 郭宏霞，杨孜. 自身免疫性疾病与病理妊娠［J］.中国实用妇科与产科杂志, 2014, 30 ( 6)：489492.
［30］ McNamee K，Dawood F，Farquharson ＲG． Thrombophilia and early pregnancy loss ［J］．Best Pract Ｒes Clin Obstet Gynaecol,2012, 26(1) : 91102.
［31］ De Jesus GR, AgmonLevin N, Andrade CA, et al. International Congress on Antiphospholipid Antibodies Task Force Report On Obstetric Antiphospholipid Syndrome ［J］. Autoimmun Rev, 2014, 13(8):795813.
［32］ Ruffatti A, Tonello M, Hoxha A, et al. Effect of additional treatments combined with conventional therapies in pregnant patients with highrisk antiphospholipid syndrome: a multicentre study ［J］. Thromb Haemost , 2018, 118(4):639646.